CroiValve Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$7M
- Investors
-
22
CroiValve General Information
Description
Developer of a minimally invasive transcatheter heart valve system designed to treat tricuspid regurgitation while preserving the native heart anatomy. The company offers an adaptable coaptation valve, a supportive anchoring system, and a procedure designed to use standard imaging, enabling physicians to treat a broad range of patients with complex tricuspid anatomies through a simpler treatment approach.
Contact Information
Website
www.croivalve.comCorporate Office
- Unit A, Liffey Trust Enterprise Centre
- 117-125 Sheriff Street Upper
- Dublin D01 F6P0
- Ireland
Corporate Office
- Unit A, Liffey Trust Enterprise Centre
- 117-125 Sheriff Street Upper
- Dublin D01 F6P0
- Ireland
CroiValve Timeline
CroiValve Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Grant | 23-Jun-2026 | $7M | Completed | Generating Revenue | ||
| 12. Later Stage VC (Series B) | 23-Jun-2026 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 18-Dec-2025 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 02-Jul-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 04-Jul-2023 | Completed | Generating Revenue | |||
| 8. Grant | 31-May-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 04-Feb-2022 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 12-Sep-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 20-Aug-2019 | $2.78M | $6.34M | Completed | Generating Revenue | |
| 4. Seed Round | 22-Mar-2019 | $3.53M | $3.56M | Completed | Generating Revenue |
CroiValve Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B Preference | ||||||||
| Ordinary | ||||||||
| Series A Preference | ||||||||
| Preference | ||||||||
| Preference | 195,953 | $0.010000 | $15.32 | $15.32 | 1x | $15.32 | 8.17% | |
| Ordinary | 7,637 | $0.010000 | $15.32 | $15.32 | 1x | $15.32 | 0.32% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
CroiValve Comparisons
Industry
Financing
Details
CroiValve Competitors (15)
One of CroiValve’s 15 competitors is Emblok, a Private Equity-Backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Emblok | Private Equity-Backed | Tampa, FL | ||||
| Micro Interventional Devices | Venture Capital-Backed | Newtown, PA | ||||
| Polares Medical | Venture Capital-Backed | Palo Alto, CA | ||||
| Colibri Heart Valve | Venture Capital-Backed | Louisville, CO | ||||
| HighLife | Venture Capital-Backed | Paris, France |
CroiValve Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CroiValve Patents
CroiValve Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260207328-A1 | Systems and methods for treating valvular regurgitation of a defective cardiac valve | Pending | 21-Jan-2025 | ||
| WO-2026159593-A1 | Systems and methods for treating valvular regurgitation of a defective cardiac valve | Pending | 21-Jan-2025 | ||
| US-20260096878-A1 | Systems and methods for treating a defective cardiac valve having antimigration features | Pending | 07-Oct-2024 | ||
| WO-2026078472-A1 | Systems for treating a defective cardiac valve having antimigration features | Pending | 07-Oct-2024 | ||
| EP-4658207-A1 | Systems and methods for delivering prosthetics to treat a cardiac valve | Active | 31-Jan-2023 | A61F2/246 |
CroiValve Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CroiValve Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BGF (Financial Services) | Growth/Expansion | Minority | ||
| Seed Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| IAG Capital Partners | Venture Capital | Minority | ||
| TedStaff Capital | Growth/Expansion | Minority |
CroiValve FAQs
-
When was CroiValve founded?
CroiValve was founded in 2016.
-
Where is CroiValve headquartered?
CroiValve is headquartered in Dublin, Ireland.
-
What is the size of CroiValve?
CroiValve has 48 total employees.
-
What industry is CroiValve in?
CroiValve’s primary industry is Surgical Devices.
-
Is CroiValve a private or public company?
CroiValve is a Private company.
-
What is CroiValve’s current revenue?
The current revenue for CroiValve is .
-
How much funding has CroiValve raised over time?
CroiValve has raised $62.7M.
-
Who are CroiValve’s investors?
BGF (Financial Services), Seed Capital, , IAG Capital Partners, and TedStaff Capital are 5 of 22 investors who have invested in CroiValve.
-
Who are CroiValve’s competitors?
Emblok, Micro Interventional Devices, Polares Medical, Colibri Heart Valve, and HighLife are some of the 15 competitors of CroiValve.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
